Breo Ellipta 25 mcg

BREO ELLIPTA 25 MCG is an inhalation powder containing vilanterol trifenate. It is used for managing respiratory conditions like asthma and COPD. This medication helps improve breathing and reduce symptoms.

BREO ELLIPTA 25 MCG is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways, making it easier to breathe. This medication is often prescribed to individuals who require long-term management of their respiratory conditions. It is not intended for immediate relief of sudden breathing problems.

Common effects of BREO ELLIPTA 25 MCG may include throat irritation, headache, and nasal congestion. Some users might experience a dry mouth or a mild increase in heart rate. These effects are generally mild and temporary. If any severe or persistent effects occur, it is advisable to consult a healthcare professional.

BREO ELLIPTA 25 MCG should be used as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. This medication should not be used to treat sudden breathing problems. Always store the inhaler in a clean, dry place and keep it out of reach of children.

BREO ELLIPTA 25 MCG may interact with other medications, including beta-blockers and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Consuming alcohol while using this medication may also increase the risk of side effects.